1OG2 | A:30-491; B:30-491 | STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9 |
1OG5 | A:30-490; B:30-490 | STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9 |
1PQ2 | A:28-490; B:28-490 | CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8 |
1R9O | A:26-492 | CRYSTAL STRUCTURE OF P4502C9 WITH FLURBIPROFEN BOUND |
1TQN | A:28-499 | CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 3A4 |
1W0E | A:25-499 | CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4 |
1W0F | A:25-498 | CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4 |
1W0G | A:25-498 | CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4 |
1Z10 | C:31-494; D:31-494; A:30-494; B:32-496 | CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND |
1Z11 | B:32-495; C:31-494; D:31-494; A:30-496 | CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND |
2F9Q | B:34-497; D:34-497; A:34-497; C:34-497 | CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6 |
2FDU | B:32-494; C:31-494; D:31-494; A:30-494 | MICROSOMAL P450 2A6 WITH THE INHIBITOR N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND |
2FDV | C:31-494; D:31-494; A:30-494; B:32-496 | MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND |
2FDW | C:31-494; D:31-494; A:30-494; B:32-496 | CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND |
2FDY | B:32-495; C:31-494; D:31-494; A:30-494 | MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND |
2J0D | B:26-496; A:29-496 | CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN |
2NNH | A:28-490; B:28-490 | CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID |
2NNI | A:28-490 | CYP2C8DH COMPLEXED WITH MONTELUKAST |
2NNJ | A:28-490 | CYP2C8DH COMPLEXED WITH FELODIPINE |
2P85 | A:31-494; B:31-494; C:31-494; D:31-494; E:31-494; F:31-494 | STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS |
2PG5 | C:32-494; A:31-494; B:32-495; D:31-494 | CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q |
2PG6 | B:32-495; C:31-494; D:31-494; A:30-494 | CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q |
2PG7 | A:31-494; B:32-495; C:31-494; D:31-494 | CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V |
2V0M | B:30-496; D:30-496; A:30-498; C:30-496 | CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE |
2VN0 | A:28-491 | CYP2C8DH COMPLEXED WITH TROGLITAZONE |
3C6G | A:39-502; B:39-505 | CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3 |
3E4E | A:31-494; B:31-494 | HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4-METHYLPYRAZOLE |
3EBS | C:31-494; D:31-494; A:30-494; B:31-496 | HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN |
3GPH | A:31-493; B:31-493 | HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID |
3IBD | A:28-492 | CRYSTAL STRUCTURE OF A CYTOCHROME P450 2B6 GENETIC VARIANT IN COMPLEX WITH THE INHIBITOR 4-(4-CHLOROPHENYL)IMIDAZOLE |
3KOH | A:31-493; B:31-493 | CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID |
3LC4 | B:31-493; A:31-493 | HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID |